Deoxyguanosine is a TLR7 agonist

Deoxyguanosine is a TLR7 agonist

Toll-like receptor 7 (TLR7) is an innate immune sensor for single-strand RNA (ssRNA). Recent structural analysis revealed that TLR7 has an additional binding site for nucleosides such as guanosine and is activated when both guanosine and ssRNA bind. The nucleoside binding site also accommodates imid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davenne, T, Bridgeman, A, Rigby, R, Rehwinkel, J
Formato:	Journal article
Lenguaje:	English
Publicado:	Wiley 2019

Ejemplares similares

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Neys Lori, et al.
Publicado: (2008-07-01)

The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
por: Shaik Mohammad Naushad, et al.
Publicado: (2023-08-01)

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.
por: Nikunj M Shukla, et al.
Publicado: (2012-01-01)

Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.
por: Xiaoyu Wang, et al.
Publicado: (2022-01-01)

The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
por: Li Zhang, et al.
Publicado: (2015-01-01)

PNP inhibitors selectively kill cancer cells lacking SAMHD1
por: Tamara Davenne, et al.
Publicado: (2020-11-01)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
por: Deepender Kaushik, et al.
Publicado: (2020-08-01)

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
por: Vasilakos John P, et al.
Publicado: (2007-10-01)

Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope
por: Maryam Mashhadi Abolghasem Shirazi, et al.
Publicado: (2023-10-01)

Varicella-Zoster virus ORF9 Is an antagonist of the DNA sensor cGAS
por: Hertzog, J, et al.
Publicado: (2020)

Determining 8-oxo-2’-deoxyguanosine/2’-deoxyguanosine ratio in DNA by reverse phase HPLC combined with amperometric detection
por: D. S. Esipov, et al.
Publicado: (2010-06-01)

Synthesis of 8-oxo-7,8-dihydro-2′-deoxyguanosine from 2′-deoxyguanosine using Cu(II)/H2O2/ascorbate: A new strategy for an improved yield
por: Patrícia S. Peres, et al.
Publicado: (2016-06-01)

Genomic 8-oxo-7,8-dihydro-2&#39;-deoxyguanosine Quantification
por: Antonio Sarno
Publicado: (2013-09-01)

Interferon induction held captive in tumor cells
por: Bridgeman, A, et al.
Publicado: (2021)

Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists.
por: Anne Månsson Kvarnhammar, et al.
Publicado: (2013-01-01)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Jinghua Sun, et al.
Publicado: (2012-01-01)

Electrophilic Substitution at C(7) of a Protected 7-Deaza-2’-deoxyguanosine – The 2’-Deoxyribonucleoside Parent Analogue of Queuosine #
por: Helmut Rosemeyer, et al.
Publicado: (2007-04-01)

Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
por: Aashna Jassal, et al.
Publicado: (2024-11-01)

ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine
por: Sehui Kim, et al.
Publicado: (2023-09-01)

A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist
por: Huju Chi, et al.
Publicado: (2022-06-01)

8-Oxo-7,8-Dihydro-2′-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development
por: Sandra K. Urbaniak, et al.
Publicado: (2020-01-01)

Varicella‐Zoster virus ORF9 is an antagonist of the DNA sensor cGAS
por: Hertzog, J, et al.
Publicado: (2022)

Viruses transfer the antiviral second messenger cGAMP between cells
por: Bridgeman, A, et al.
Publicado: (2015)

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
por: Craig L Slingluff, et al.
Publicado: (2021-05-01)

A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models
por: Bethany Crouse, et al.
Publicado: (2023-07-01)

T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
por: Verena Turco, et al.
Publicado: (2023-02-01)

Biotinylation of Deoxyguanosine at the Abasic Site in Double-Stranded Oligodeoxynucleotides
por: Chun Wu
Publicado: (2016-01-01)

Mitochondrial deoxyguanosine kinase is required for female fertility in mice
por: Gao Yake, et al.
Publicado: (2024-02-01)

1161 Development of TLR7- and STING-conjugatable agonists for immunostimulatory ADC-based cancer therapies
por: Fabienne Vernejoul, et al.
Publicado: (2023-11-01)

8-Oxo-2’-deoxyguanosine – biomarker of the oxidative stress
por: T. S. Nevredimova, et al.
Publicado: (2014-10-01)

Sequence-Dependent Variation in the Reactivity of 8-Oxo-7,8-dihydro-2′-deoxyguanosine toward Oxidation
por: Lim, Kok Seong, et al.
Publicado: (2014)

Formulated Phospholipids as Non-Canonical TLR4 Agonists
por: Hong Liang, et al.
Publicado: (2022-11-01)

The mechanism of decomposition of N-methyl-N-nitrosourea (MNU) in water and a study of its reactions with 2'-deoxyguanosine, 2'-deoxyguanosine 5'-monophosphate and d(GTGCAC)
por: Golding, B, et al.
Publicado: (1997)

Deoxyguanosine kinase deficiency: natural history and liver transplant outcome
por: Manzoni, E, et al.
Publicado: (2024)

Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy
por: Varshney, Dhruv, et al.
Publicado: (2022)

Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy
por: Varshney, Dhruv, et al.
Publicado: (2021)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers
por: Joseph F. Grippo, et al.
Publicado: (2021-07-01)

Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate
por: Douglas E. Stack
Publicado: (2015-09-01)

Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists
por: Linda K. Curtiss, et al.
Publicado: (2012-10-01)

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
por: Katherine A. Michaelis, et al.
Publicado: (2019-10-01)